Paul Conyngham used AI to pinpoint the mutations in his dog Rose's tumor — and used the data to have a treatment made just ...
Next Conyngham used Grok to design an mRNA vaccine that boosts the production of tumor-associated antigens enabling Rosie's ...
Paul Conyngham, a tech entrepreneur and AI expert, pursued the project after veterinarians gave Rosie only a few months to ...
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
After spending thousands on chemotherapy and surgery for little payoff, tech entrepreneur Paul Conyngham paired with an ...
"The vaccine pushed back about 75 percent of the cancer," the dog owner, tech entrepreneur Paul Conyngham, said.
The viral Rosie story credited AI with designing a custom cancer vaccine. The scientists who actually made it say the credit ...
When his beloved dog was given months to live, an Australian man harnessed the power of machine learning and mRNA technology ...
Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be ...
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are spending billions to bring the same technology to human patients.
The Brighterside of News on MSN
New injectable system reprograms cancer-fighting T cells inside the body
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...
HHS plans 200M cancer vaccine initiative to fund public-private partnerships studying vaccines for high-risk cancer patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results